Thyroid antibody levels in diabetes patients
Part of Hormones & metabolism clinical trials.
This study checks for certain thyroid-related antibodies in people with diabetes, which might help understand a link between diabetes and thyroid health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old.
- You have been diagnosed with diabetes.
- You have no history of thyroid disease or thyroid surgery.
- You are not currently taking any thyroid hormone or anti-thyroid medication.
- You have not taken any medications that affect thyroid function in the last 3 months.
- You are not pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how inflammation and antioxidant levels relate to type 2 diabetes. It may help understand how diet and supplements could affect diabetes management.
This study looks at how belly fat affects heart health in people with type 2 diabetes. It may help find ways to lower heart risks for people like you.
This study checks if people with autoimmune thyroid disease may also be at risk for developing type 1 diabetes. It looks at the body's attack on insulin-producing cells in the pancreas, using blood tests to catch early signs.
This study looks at how thyroid problems might be linked to diabetes in people with type 2 diabetes. It aims to find out if checking thyroid function can help manage diabetes better.
This study measures “circulating biomarkers” (blood-based signals) in people with type 1 or type 2 diabetes, and in some people without diabetes who test positive for certain diabetes antibodies. The goal is to understand what these blood signals can tell us about diabetes development and progression.
This study follows people who have islet autoantibodies (markers in the blood that can increase the risk of type 1 diabetes) but do not have diabetes yet. The goal is to better understand how these antibodies affect health over time.
Hear when a new Diabete Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.